Company Filing History:
2 out of 5 
2 out of 3 
2 out of 2 
Years Active: 2006-2017
Title: Inventor Peer Friedrich Stähler - Innovator in Biomedical and Polymer Technologies
Introduction
Peer Friedrich Stähler, based in Mannheim, Germany, is a noteworthy inventor recognized for his contributions to the fields of biomedicine and polymer technology. With a remarkable portfolio comprising eight patents, he has made significant advancements that have potential implications for diagnostics and materials science.
Latest Patents
Among Stähler's latest inventions is a groundbreaking patent titled "Complex miRNA sets as novel biomarkers for an acute coronary syndrome." This invention pertains to the use of single polynucleotides or sets of polynucleotides for the detection of miRNAs, which can be pivotal in diagnosing and prognosing acute coronary syndrome through blood samples from humans. The invention also includes methodologies for establishing expression profiles of miRNAs relevant to the condition, thus offering a powerful tool for medical diagnostics.
Another notable patent is related to a "Method for producing polymers," focusing on the production of synthetic nucleic acid double strands of various sequences. This innovation reflects Stähler's expertise in advancing polymer production techniques.
Career Highlights
Throughout his career, Peer Friedrich Stähler has worked at esteemed companies such as Febit Holding GmbH and Febit Biotech GmbH. His roles in these organizations have enabled him to apply his innovative ideas to real-world applications, bridging the gap between scientific research and practical implementation.
Collaborations
Stähler has also collaborated with distinguished colleagues, including Cord Friedrich Stähler and Manfred Müller. These partnerships have enriched his projects and contributed to the successful development of his patented technologies.
Conclusion
In conclusion, Peer Friedrich Stähler is a remarkable inventor whose contributions to acute coronary syndrome diagnostics and polymer production showcase his innovative spirit. As the landscape of biomedical technologies continues to evolve, Stähler's patents and collaborative efforts exemplify the impact that dedicated inventors can have on advancing science and improving healthcare solutions.